Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Aspartame

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 19Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    European Medicines Agency (EMA) publishes information on excipients for labeling & package leaflet of human medicines
    European Medicines Agency (EMA) publishes information on excipients for labeling & package leaflet of human medicines

    01 Jan 2019

    // EMA

    https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/product-information/reference-guidelines/excipients-labelling

    EMA
    01 Jan 2019
    Share Share
    STEP database - Safety and Toxicity of Excipients for Paediatrics
    STEP database - Safety and Toxicity of Excipients for Paediatrics

    09 Feb 2016

    // PHARMA-EXCIPIENTS

    http://www.pharma-excipients.ch/2016/02/10/step-database-safety-and-toxicity-of-excipients-for-paediatrics/

    PHARMA-EXCIPIENTS
    09 Feb 2016
    Share Share